Keenova Therapeutics plc Deferred Compensation Liability, Current and Noncurrent
Keenova Therapeutics plc had Deferred Compensation Liability, Current and Noncurrent of $18.70 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent · last filed 2026-08-11
- 2026-06-30: Deferred Compensation Liability, Current and Noncurrent $18.70M.
- 2026-03-31: Deferred Compensation Liability, Current and Noncurrent $19.80M.
- 2025-12-31: Deferred Compensation Liability, Current and Noncurrent $21.70M.
- 2024-12-27: Deferred Compensation Liability, Current and Noncurrent $12.60M.
| Period end | Deferred Compensation Liability, Current and Noncurrent |
|---|---|
| 2026-06-30 | $18.70M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $19.80M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $21.70M 10-Q · filed 2026-08-11 |
| 2024-12-27 | $12.60M 10-K · filed 2026-04-15 |